Reimann named to NIH council

Published on
information-circle This article is more than 3 years old

Dr. Keith Reimann, a professor at the University of Massachusetts Medical School and senior director of product discovery at MassBiologics, has been appointed to the National Institutes of Health Council of Councils, the agency announced in June.

Dr. Reimann
Dr. Keith Reimann (Courtesy of UMass Medical School)

He is one of eight individuals named to the council whose 27 members advise the NIH director on research representing important areas of emerging scientific opportunities, rising public health challenges, or knowledge gaps deserving of special emphasis. A major function of the council is to make recommendations on research proposals for funding by the agency.

As an internationally known comparative immunologist, Dr. Reimann (Michigan State ’79) has developed models of infectious disease and transplantation in nonhuman primates. His research in these primates has involved the study of disease pathogenesis and the testing of new vaccines and treatments. Dr. Reimann has over 20 years of experience in antibody discovery, engineering, and preclinical testing.

His term on the Council of Councils runs through October 2017.